Screener
Jade Biosciences JBIO Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other income (expense), net | 3,093 | (14,785) |
| Net loss before income tax expense | (40,352) | (38,169) |
| Income tax expense | (16) | — |
| Net loss | $(40,368) | $(38,169) |
| Other comprehensive income (loss): | ||
| Currency translation adjustment | 2 | — |
| Unrealized loss on investments | (473) | — |
| Comprehensive loss | $(40,839) | $(38,169) |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's net income?
- Jade Biosciences (JBIO) reported net income of -$40.37M in Q1 2026.
- How has Jade Biosciences's net income changed year-over-year?
- Jade Biosciences's net income decreased by 5.8% year-over-year, from -$38.17M to -$40.37M.
- What is the long-term trend for Jade Biosciences's net income?
- Over 4 years (2021 to 2025), Jade Biosciences's net income has grown at a 53.5% compound annual growth rate (CAGR), from -$22.96M to -$127.41M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Jade Biosciences's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude